ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L04AB01 | BioTech | Etanercept - 50mg | 10399 | 117119/1 | ENBREL | 50mg | 4 | Injectable solution | SC | Food & Drug Corporation FDC | Pfizer Manufacturing Belgium NV | Belgium | 856,168 L.L | 10.71 | E1 | Pfizer Europe MA EEIG | Belgium | 2/5/2024 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L04AB01 | BioTech | Etanercept - 50mg/1ml | 10377 | 138419/1 | ALTEBREL | 50mg/1ml | 4 | Injectable solution | SC | Lebiran SARL | Aryogen Pharmed | Iran | 2,433,099 L.L | 10.71 | E1 | Aryogen Pharmed | Iran | 2/5/2024 | |
L04AB01 | BioTech | Etanercept - 50mg | 10398 | 165119/1 | ENBREL | 50mg | 4 | Injectable solution | SC | Food & Drug Corporation FDC | Pfizer Manufacturing Belgium NV | Belgium | 856,168 L.L | 10.71 | E1 | Pfizer Europe MA EEIG | Belgium | 2/5/2024 | |
L04AB01 | BioTech | Etanercept - 50mg | 9755 | 53119/1 | ERELZI | 50mg | 4 | Injectable solution | SC | Khalil Fattal & Fils S.A.L. | Sandoz GmbH, (Schaftenau) | Austria | 904,040 L.L | 10.71 | E1 | Sandoz GmbH, Kundl | Austria | 2/5/2024 | |
L04AB01 | BioTech | Etanercept - 50mg | 9756 | 53019/1 | ERELZI | 50mg | 4 | Injectable solution | SC | Khalil Fattal & Fils S.A.L. | Sandoz GmbH, (Schaftenau) | Austria | 798,816 L.L | 10.71 | E1 | Sandoz GmbH, Kundl | Austria | 2/5/2024 | |
L04AB01 | BioTech | Etanercept - 50mg/1ml | 10377/945 | 138419/1 | ALTEBREL | 50mg/1ml | 4 | Injectable solution | SC | Lebiran SARL | Aryogen Pharmed | Iran | 14,833,767 L.L | 10.71 | E1 | Aryogen Pharmed | Iran | 2/5/2024 | 0 |
L04AB01 | BioTech | Etanercept - 50mg | 10398/945 | 165119/1 | ENBREL | 50mg | 4 | Injectable solution | SC | Food & Drug Corporation FDC | Pfizer Manufacturing Belgium NV | Belgium | 52,197,598 L.L | 10.71 | E1 | Pfizer Europe MA EEIG | Belgium | 2/5/2024 | 0 |
L04AB01 | BioTech | Etanercept - 50mg | 10399/945 | 117119/1 | ENBREL | 50mg | 4 | Injectable solution | SC | Food & Drug Corporation FDC | Pfizer Manufacturing Belgium NV | Belgium | 52,197,598 L.L | 10.71 | E1 | Pfizer Europe MA EEIG | Belgium | 2/5/2024 | 0 |
L04AB01 | BioTech | Etanercept - 50mg | 9755/945 | 53119/1 | ERELZI | 50mg | 4 | Injectable solution | SC | Khalil Fattal & Fils S.A.L. | Sandoz GmbH, (Schaftenau) | Austria | 55,116,226 L.L | 10.71 | E1 | Sandoz GmbH, Kundl | Austria | 2/5/2024 | 0 |
L04AB01 | BioTech | Etanercept - 50mg | 9756/945 | 53019/1 | ERELZI | 50mg | 4 | Injectable solution | SC | Khalil Fattal & Fils S.A.L. | Sandoz GmbH, (Schaftenau) | Austria | 38,118,333 L.L | 10.71 | E1 | Sandoz GmbH, Kundl | Austria | 2/5/2024 | 0 |